10X genomics, INC.:1279204 [25-003650]

Ended Awarded Last action

Contract number
75N92B25F90046
Awardee
Awarding agency
Obligated
$24,339

Award facts

Contract value 100% obligated
$24,339.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a BPA call to 10X Genomics, Inc. with a ceiling value of $24,339.00 and an award date of September 15, 2025. The call is for Chromium Next GEM chip single-cell kits and Chromium Next GEM single-cell ATAC kits (16 reactions each), with an ultimate completion date of September 14, 2026. Performance occurs in Pleasanton, California. No set-aside applies to this call.

Quick answers

Who was awarded contract 75N92B25F90046?

75N92B25F90046 was awarded to 10X Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 15, 2025.

How much is contract 75N92B25F90046 worth?

The government has obligated $24,339 on 75N92B25F90046.

Is contract 75N92B25F90046 an order under another contract?

Yes. 75N92B25F90046 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92B25F90046 competed?

The extent of competition for 75N92B25F90046 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award